Valneva Shares Slump After FDA Postpones Chikungunya Vaccine Review Date

By Maitane Sardon Shares in Valneva plunged in early trading Monday after the French biotech company said the U.S. Food and Drug Administration has delayed...

Related Keywords

France ,French ,Maitane Sardon ,Drug Administration ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Vaccines ,Healthcare Life Sciences ,Biopharmaceuticals ,Specialized Drugs Medications ,Regulation Government Policy ,Financial Performance ,Share Price Movement Disruptions ,Corporate Actions ,Corporate Industrial News ,Stock Trading Disruptions ,Political General News ,Health ,Immunizations ,Medical Conditions ,Vector Borne Zoonotic Diseases ,Infectious Diseases ,Medical Treatments Procedures ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Valneva Se ,Vla Fr ,Fr Vla ,Regulation ,Government Policy ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Political ,General News ,Vector Borne ,Zoonotic Diseases ,Medical Treatments ,Procedures ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,